Massive 150,000-Person study tracks heart risks in diabetes patients
NCT ID NCT06608212
Summary
This study is collecting health records from 150,000 people in the US who have chronic kidney disease and type 2 diabetes. Researchers are comparing the health of people who take the approved drug finerenone with those who don't, to see if it helps prevent heart attacks and heart failure hospitalizations in everyday medical care. No new treatments or visits are required—the study only analyzes existing patient data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bayer
Whippany, New Jersey, 07981, United States
Conditions
Explore the condition pages connected to this study.